Loading clinical trials...

Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT00552214

Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens

The purpose of this study is to validate the performance characteristics of an assay that tests for HIV-1, HCV and HBV on an automated blood bank instrument for registration submission.

Lead sponsor: Novartis•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment10,290

Start dateAug 2007

Last updatedFeb 21, 2021

Locations shown

Taipei Blood Center Taiwan Blood Service Foundation (TBSF)

Taipei

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 21, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions